News

According to Karl Storz, the instrument set includes a pluggable, segmented dummy (a type of vaginal dilator) used for initial dilation, straight and curved thread guides for placing

Under the agreement, the purchase price will depend on the achievement of milestone payments related to the development of BSI-201 which could achieve a maximum of $500 million.

The company has reported sales of $15 billion for the first quarter of 2009, a decrease of 7.2%, compared to $16.19 billion for the first quarter of 2008.

NeoStem, a provider of adult stem cell collection and banking services, has completed a private placement financing totaling $11m from three Asia-based investors, including a private equity firm

The reported losses included non-cash stock-based compensation charges for the quarters ended December 31, 2008 and 2007 of approximately $236,000 and $533,000, respectively. For the fiscal year ended

Pharming is entitled to request Yorkville Advisors Global Master (YA Global) to subscribe to and purchase newly issued shares in regular tranches of up to E400,000 per tranche.

The company recorded operating income of $0.9 million for the three-month period, compared to $2.7 million for the prior-year period. In the company’s Laboratory Segment, revenues from drugs-of-abuse

Centocor Ortho Biotech, a wholly-owned subsidiary of Johnson & Johnson, and Schering-Plough have announced that Health Canada has granted approval of Simponi as a once-monthly, subcutaneous therapy for

The research collaboration involves the preclinical application of ImmunoVaccine Technologies’s (IVT’s) DepoVax vaccine formulation to anthrax antigens to explore new methods to prevent, prepare for, and respond to